BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 16942942)

  • 1. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
    Nadar S; Blann AD; Lip GY
    Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.
    Nadar SK; Blann AD; Lip GY
    J Intern Med; 2004 Oct; 256(4):331-7. PubMed ID: 15367176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients.
    Ferroni P; Martini F; D'Alessandro R; Magnapera A; Raparelli V; Scarno A; Davì G; Basili S; Guadagni F
    Clin Chim Acta; 2008 Feb; 388(1-2):33-7. PubMed ID: 18001701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.
    Nadar S; Blann AD; Lip GY
    Ann Med; 2004; 36(7):552-7. PubMed ID: 15513305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma markers of angiogenesis in pregnancy induced hypertension.
    Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
    Caine GJ; Ryan P; Lip GY; Blann AD
    Cancer Lett; 2007 Jun; 251(2):296-301. PubMed ID: 17240049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
    Lee KW; Lip GY; Blann AD
    Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
    Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
    Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.
    Celik T; Yuksel UC; Iyisoy A; Kursaklioglu H; Ozcan O; Kilic S; Ozmen N; Isik E
    Int J Cardiol; 2007 Mar; 116(2):206-11. PubMed ID: 16822563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
    J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
    J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
    Caine GJ; Stonelake PS; Lip GY; Blann AD
    Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
    Choudhury A; Chung I; Blann AD; Lip GY
    J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation in pregnancy-induced hypertension.
    Karalis I; Nadar SK; Al Yemeni E; Blann AD; Lip GY
    Thromb Res; 2005; 116(5):377-83. PubMed ID: 16122550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble P-selectin as a marker of in vivo platelet activation.
    Ferroni P; Martini F; Riondino S; La Farina F; Magnapera A; Ciatti F; Guadagni F
    Clin Chim Acta; 2009 Jan; 399(1-2):88-91. PubMed ID: 18835553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.